Since both PAR2 and ALK5 are expressed by skeletal muscle [48], it is conceivable that serine proteinases released by the tumor tissue (either malignant epithelial cells, stromal cells or immune cells) activate PAR2 and further enhance myostatin signaling in muscle cells, ultimately leading to muscle wasting. The gene discussed is TGFBR1; the disease is neoplasm.